47 related articles for article (PubMed ID: 1986099)
1. Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a.
White CW; Wolf SJ; Korones DN; Sondheimer HM; Tosi MF; Yu A
J Pediatr; 1991 Jan; 118(1):59-66. PubMed ID: 1986099
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary capillary hemangiomatosis: a focus on the EIF2AK4 mutation in onset and pathogenesis.
Ma L; Bao R
Appl Clin Genet; 2015; 8():181-8. PubMed ID: 26300654
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus for the treatment of children with various complicated vascular anomalies.
Lackner H; Karastaneva A; Schwinger W; Benesch M; Sovinz P; Seidel M; Sperl D; Lanz S; Haxhija E; Reiterer F; Sorantin E; Urban CE
Eur J Pediatr; 2015 Dec; 174(12):1579-84. PubMed ID: 26040705
[TBL] [Abstract][Full Text] [Related]
4. Treatment of an aggressive haemangiomatous lesion with alpha-interferon.
Ibrahim Z; King PA; Brennan B; Cole CH
Pediatr Surg Int; 1996 Jun; 11(5-6):366-9. PubMed ID: 24057717
[TBL] [Abstract][Full Text] [Related]
5. Vascular sarcomas.
Ravi V; Patel S
Curr Oncol Rep; 2013 Aug; 15(4):347-55. PubMed ID: 23852636
[TBL] [Abstract][Full Text] [Related]
6. Non-congenital heart disease associated pediatric pulmonary arterial hypertension.
Ivy DD; Feinstein JA; Humpl T; Rosenzweig EB
Prog Pediatr Cardiol; 2009 Dec; 27(1-2):13-23. PubMed ID: 21852894
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary capillary haemangiomatosis in children and adolescents: report of a new case and a review of the literature.
Bartyik K; Bede O; Tiszlavicz L; Onozo B; Virag I; Turi S
Eur J Pediatr; 2004 Dec; 163(12):731-7. PubMed ID: 15365825
[TBL] [Abstract][Full Text] [Related]
8. Duodeno-jejunal hemangiomatosis.
Lakhkar B; Abubacker S
Indian J Pediatr; 2000 Dec; 67(12):931-3. PubMed ID: 11262994
[TBL] [Abstract][Full Text] [Related]
9. Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents.
Kakeji Y; Teicher BA
Invest New Drugs; 1997; 15(1):39-48. PubMed ID: 9195288
[TBL] [Abstract][Full Text] [Related]
10. Kasabach-Merritt syndrome and Down's syndrome.
Ram SP
J R Soc Med; 1997 Mar; 90(3):159-60. PubMed ID: 9135617
[No Abstract] [Full Text] [Related]
11. Interferon-alpha therapy for multiple hemangiomas associated with coarctation of the aorta.
Hijii T; Fukushige J; Tasaki K; Ueda K
Heart Vessels; 1996; 11(4):211-4. PubMed ID: 9119811
[TBL] [Abstract][Full Text] [Related]
12. A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).
Teicher BA
Cancer Metastasis Rev; 1996 Jun; 15(2):247-72. PubMed ID: 8842498
[No Abstract] [Full Text] [Related]
13. Cavernous haemangioma with Kasabach-Merritt syndrome: treatment with alpha-interferon.
Ettlinger JJ; Fleming PJ; Joffe HS; Kennedy CT
J R Soc Med; 1996 Jan; 89(1):55P-6P. PubMed ID: 8709089
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects.
Battegay EJ
J Mol Med (Berl); 1995 Jul; 73(7):333-46. PubMed ID: 8520966
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha-2a for the treatment of complex hemangiomas of infancy and childhood.
Ricketts RR; Hatley RM; Corden BJ; Sabio H; Howell CG
Ann Surg; 1994 Jun; 219(6):605-12; discussion 612-4. PubMed ID: 8203969
[TBL] [Abstract][Full Text] [Related]
16. Mice with hemangiomas induced by transgenic endothelial cells. A model for the Kasabach-Merritt syndrome.
Dubois-Stringfellow N; Kolpack-Martindale L; Bautch VL; Azizkhan RG
Am J Pathol; 1994 Apr; 144(4):796-806. PubMed ID: 8160778
[TBL] [Abstract][Full Text] [Related]
17. Cellular markers that distinguish the phases of hemangioma during infancy and childhood.
Takahashi K; Mulliken JB; Kozakewich HP; Rogers RA; Folkman J; Ezekowitz RA
J Clin Invest; 1994 Jun; 93(6):2357-64. PubMed ID: 7911127
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of wound healing in mice by local interferon alpha/beta injection.
Stout AJ; Gresser I; Thompson WD
Int J Exp Pathol; 1993 Feb; 74(1):79-85. PubMed ID: 7682435
[TBL] [Abstract][Full Text] [Related]
19. Interferon alfa-2a modifies the course of subfoveal and juxtafoveal choroidal neovascularisation.
Engler C; Sander B; Villumsen J; Lund-Andersen H
Br J Ophthalmol; 1994 Oct; 78(10):749-53. PubMed ID: 7528534
[TBL] [Abstract][Full Text] [Related]
20. Diffuse pulmonary angiomatosis.
Canny GJ; Cutz E; MacLusky IB; Levison H
Thorax; 1991 Nov; 46(11):851-3. PubMed ID: 1771607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
